Buradasınız

Ortalama Eritrosit Hacmi Düzeyinin Alkolik Karaciğer Sirozu Tanısındaki Yerinin Belirlenmesi ve Prognoza Etkisinin İrdelenmesi

Determination of the Role of Mean Corpuscular Volume Level on the Diagnosis of Alcoholic Liver Cirrhosis and Investigation of Its Effect on the Prognosis

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Objectives: In this study, we aimed to determine the relationship between macrocytosis and Alcoholic Liver Cirrhosis (ALC) and its accuracy, sensitivity and specificity rates. Material and Methods: Mean corpuscular volume (MCV) levels of 46 patients diagnosed as having ALC (Group 1) and 51 patients diagnosed as having Hepatitis B cirrhosis and Hepatitis C cirrhosis (Group 2) were compared retrospectively. Results: MCV level determined as 94.6±10.87 in patients in Group 1 was statistically significantly higher than in patients in Group 2 (p<0.001). Macrocytosis was determined in 26 patients (56.52%) in Group 1 but in 3 patients (5.88%) in Group 2. When the cut-off value for MCV in the diagnosis of ALC was taken as 102 fl, its accuracy, sensitivity and specificity rates for the diagnosis were determined as 78%, 93% and 72% respectively. MCV levels of Child class C ALC patients (n=27) were determined statistically significantly higher than MCV levels of Child class A and Child class B ALC patients. Conclusion: We concluded that MCV level is an important variable for the diagnosis of ALC but it is insufficient alone for the diagnosis; macrocytosis frequency increases in these patients and MCV levels increase as the prognosis worsens even without existence of anemia. ©2008, Firat University, Medical Faculty
Abstract (Original Language): 
Amaç: Alkolik karaciğer sirozunda(AKS) makrositoz sıklığı ve makrositoz ile prognoz arasındaki ilişkinin belirlenerek doğruluk, duyarlılık ve özgüllük değerlerinin tespiti amaçlanmıştır. Gereç ve Yöntem: AKS tanısı olan toplam 46 hasta(grup 1)ile Hepatit B ve C virüslerine bağlı karaciğer sirozu (KS)tanısı olan 51 hastanın(grup 2) ortalama eritrosit hacmi(OEH) düzeyleri retrospektif olarak karşılaştırıldı. Bulgular: Grup 1'de OEH değeri 94.6±10.87 olup, grup 2 hastalardan anlamlı olarak yüksek saptandı(p<0.001).Grup 1'de toplam 26 (%56.52)hastada makrositoz tespit edilirken, grup 2 hastalarda bu oran 3(%5.88)idi. AKS tanısında OEH için cut-off değeri 102 fl olarak alındığında, tanı için doğruluk %78, duyarlılık %93 ve özgüllük %72 olarak saptandı. Child C grubu AKS tanılı hastaların(n=27) OEH'nin Child A ve B AKS tanılı hastalara oranla anlamlı olarak yüksek olduğu tespit edildi. Sonuç: AKS tanısında OEH'nin oldukça önemli olduğu fakat tek başına tanıdaki doğruluğunun yetersiz olduğu, anemi olmaksızın da bu hastalarda makrositoz sıklığının arttığı ve prognoz kötüleştikçe OEH değerinin de arttığı kanısına varıldı ©2008, Fırat Üniversitesi, Tıp Fakültesi
49-52

REFERENCES

References: 

1. Rutherford CJ, Frenkel PF. Hemostatic disorders in liver disease. In:Schiff ER Sorrell MF, Maddrey WC (Editors). Schiffs Diseases of the Liver. 8. edition , Philedelphia-New York:
Lippincott-Raven Publishers, 1999: 583-598
2. Pasqualetti P, Festuccia V, MacCarone C, DiLaura G, Casale R. Diagnostic value of gamma glutamyl transpeptidase and the mean corpusculer volume in chronic hepatitis of alcoholic etiology.
Minerva Med 1995; 86: 395-402
3. Soysal T. Megaloblastic Anemias. In: Soysal T, Soycan LY (Editors). Continuous Medical Education Symposium Serial of Cerrahpasa Medical Faculty of Istanbul University. Istanbul:
Kaya Publishers, 2001: 33-47
4. Mates M, Heyd J, Soununjon M et all. The haematologist as watcdog of community health by full blood count. QJM 1995;
88: 333-339
5. Riedler GF, Zollinger P, Schmid M. Changes in the blood picture in liver diseases. Schweiz Med Wochenshr 1975; 105: 1593
6. Intragumtornchai T, Rojnukkarin P, Swasdikul D, Vajanamarhutue C, Israsena S. Anemias in Thai patients with cirrhosis. Int J Hematol(Ireland) 1997; 65: 365-373
7. Maruyama S, Hirayama C, Yamamato et all. Red blood cell status in alcoholic and non-alcoholic liver diseases. J Lab Med 2001:
138: 332-337
Tanrıverdi ve Ark
8. Sherlock S, Dooley J. Alcohol and liver. In:Sherlock S, Dooley J (Editors). Diseases of the liver and biliary system. 10. baskı,
Oxford: Blackwell Science Ltd, 1997: 385-400
9. Wu A, Chanarin I, Slavin G, Levi AJ. Folate deficiency in the alcoholics-its relationship to clinical and haematological abnormalities, liver disease and folate stores. Br Haematol 1975;
29: 469-478
10. Seppa K, Sillanaukee P. Women, alcohol and red cells. Alcohol Clin Exp Res. 1994: 18: 1168-1171
11. Oski FA. Anemia due to other nutritional deficiencies. In: Beutler
E, Lichtman MA, Coller BS, Kipps TJ (Editors). Williams
Hematology. 5. baskı, McGraw Hill Health Professions Division
International Edition, 1995: 511-514
12. Balcells A, Ingelmo M, Vivancos J et all. Macrocytosis in chronic alcoholism (author's transl). Med Clin (barc) 1979; 73 :312-314
13. Gheno G, Magnabosco V, Mazzei G. Macrocytosis and anemia in chronic alcoholism. Correlation with the results of hepatic needle biopsy. Minerva Med 1981; 72: 1301-1306
14. Yersin B, Nicolet JF, Dercy et all. Screening for excessive alcohol drinking; comparative value of carbohaydrate deficient transferin, gamma glutamyl transpeptidase and mean corpuscular
volume. Arch Intern Med 1995; 155: 1907-1911
15. Sun L, Konig IR, Jacobs A, et al. Mean corpuscular volume and ADH1C genotype in white patients with alcohol-associated
diseases. Alcohol Clin Exp Res 2005;29:788-93

Thank you for copying data from http://www.arastirmax.com